Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT02489123 · TERMINATED

Trial details

NCT number: NCT02489123
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ann Arbor Stage I Mantle Cell Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma Ann Arbor Stage III Mantle Cell Lymphoma Ann Arbor Stage IV Mantle Cell Lymphoma Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma

Start date: 2015-08-11
Primary completion: 2020-06-16
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.